To bolster the US government’s vaccine policymaking process and restore trust in immunization, the Vaccine Integrity Project (VIP) at the University of Minnesota’s Center for Infectious Disease Research and Policy (CIDRAP) and The Evidence Collective today announced new research efforts.
“The questions facing vaccine recommendations today are larger than any single administration or any single committee,” Michael Osterholm, PhD, MPH, CIDRAP director and VIP founder, said in a press release. “More than 60 years after ACIP (Advisory Committee on Immunization Practices) was established, this is an opportunity to assess how an independent scientific advisory process can best serve the country in an increasingly complex scientific, technological, and political environment.”
‘The future of vaccine policy’
The VIP and The Evidence Collective will focus on different aspects of research to provide guidance for the reshaping of federal vaccine oversight and fostering increased public trust.
Using information gathered from sessions with 80 to 100 public health stakeholders, members of the public, and comparative analysis of committees, the VIP will examine how ACIP and the Centers for Disease Control and Prevention (CDC) have assessed and recommended vaccines and will offer ways to improve this process.
